文献速递眼底病与葡萄膜炎

新生血管性年龄相关性黄斑变性与息肉状脉络膜血管病变中脉络膜前裂隙的长期病程与视力结局

LONG-TERM COURSE AND VISUAL OUTCOMES OF PRECHOROIDAL CLEFT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
PubMed 文献 · Retina · 2021-01-01

这项回顾性研究纳入61例接受抗VEGF治疗的脉络膜前裂隙患者,随访52.4±17.4个月。27.9%的患者裂隙消退,消退组视力下降程度较轻;新生血管性AMD组视力下降较PCV组更重。

要点

  • 约27.9%的脉络膜前裂隙在抗VEGF治疗后可消退,平均消退时间25.7±18.3个月。
  • 裂隙未消退组logMAR视力下降程度显著大于消退组(0.59±0.56 vs 0.25±0.61,P=0.007)。
  • 新生血管性AMD组视力下降程度显著大于PCV组(0.56±0.61 vs 0.18±0.33,P=0.034)。

核心结论

  • 约27.9%的脉络膜前裂隙最终消退,并伴随相对较好的视力结局。
  • 新生血管性AMD伴脉络膜前裂隙者视力预后较差,需更加谨慎。

研究设计与样本

  • 回顾性研究纳入61例接受抗VEGF治疗的脉络膜前裂隙患者。
  • 按裂隙是否消退分为消退组与非消退组,按新生血管类型分为新生血管性AMD组与PCV组。
  • 随访52.4±17.4个月,比较各组视力变化。

主要发现

  • 随访期间17例(27.9%)裂隙消退,平均消退时间25.7±18.3个月。
  • 非消退组logMAR视力下降0.59±0.56(n=17),消退组0.25±0.61(n=44),P=0.007。
  • 新生血管性AMD组logMAR视力下降0.56±0.61(n=51),PCV组0.18±0.33(n=10),P=0.034。

临床怎么用

  • 对新生血管性AMD伴脉络膜前裂隙患者应加强随访和视力监测。
  • 抗VEGF治疗过程中需关注裂隙是否消退,以评估视力预后。

局限性

  • 回顾性研究设计。
  • PCV组样本量仅10例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the regression of prechoroidal cleft, its influence on visual outcomes, and differences in visual outcomes between neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. METHODS: This retrospective study included 61 patients exhibiting prechoroidal cleft who were treated with antivascular endothelial growth factors. The patients were divided into two groups according to the following categories: 1) regression of prechoroidal cleft: regression group versus nonregression group and 2) type of neovascularization: neovascular age-related macular degeneration group versus polypoidal choroidal vasculopathy group. Changes in the visual acuity during the follow-up period were also compared between the two groups. RESULTS: During the 52.4 ± 17.4-month follow-up period, regression of prechoroidal cleft was noted in 17 patients (27.9%) at a mean of 25.7 ± 18.3 months after the first identification. The degree of the logarithm of the minimum angle of resolution of visual deterioration was greater in the nonregression group (0.59 ± 0.56, n = 17) than that in the regression group (0.25 ± 0.61, n = 44) (P = 0.007) and in the neovascular age-related macular degeneration group (0.56 ± 0.61, n = 51) than that in the polypoidal choroidal vasculopathy group (0.18 ± 0.33, n = 10) (P = 0.034). CONCLUSION: Approximately 27.9% of prechoroidal cleft cases eventually regressed, in conjunction with relatively favorable visual outcomes. Considering the poor visual prognosis in neovascular age-related macular degeneration accompanied by prechoroidal cleft, more caution is required for this condition.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Kim JH, Kim JW, Kim CG, et al. LONG-TERM COURSE AND VISUAL OUTCOMES OF PRECHOROIDAL CLEFT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY. Retina. 2021. PMID: 34173365. doi:10.1097/IAE.0000000000003242

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。